US Giant Apollo Bags Billion-Euro Partnership with Sofinnova
As biotech investment slows following a record-breaking year, the Paris-based Sofinnova Partners has landed a…
As biotech investment slows following a record-breaking year, the Paris-based Sofinnova Partners has landed a…
Tapping into the increasingly sophisticated market for meat alternatives, the Swedish synthetic biology startup Melt&Marble…
The World Health Organization has released a 10-year plan to monitor the genetic make-up of…
Low-cost genetic sequencing is becoming increasingly accessible and profitable for companies, but data protection and…
Cystic fibrosis has proved resistant to treatments that provide long-lasting respite from the sticky mucus…
US regulators have approved the first-in-class drug efgartigimod for the treatment of the rare muscle…
The US venture capital firm Apple Tree Partners (ATP) is making its first transatlantic foray…
New, more targeted treatments are on the horizon for the rare autoimmune disease ANCA-associated vasculitis,…
As this month’s COP26 United Nations climate summit highlighted the climate change emergency, venture capital…
With many targeted protein degraders hitting the clinic, lucrative collaborations and acquisitions are being signed…
Despite vast amounts of funding entering the cell and gene therapy field, the manufacture of…
Confidence in gene-edited T cell therapies from donor cells has faltered as Allogene Therapeutics paused…